Journal article

RIPK1-and RIPK3-induced cell death mode is determined by target availability

WD Cook, DM Moujalled, TJ Ralph, P Lock, SN Young, JM Murphy, DL Vaux

Cell Death & Differentiation | NATURE PUBLISHING GROUP | Published : 2014


Awarded by NHMRC

Awarded by Cancer Council Victoria

Awarded by Cure Cancer Australia Foundation

Awarded by Center Grant from Leukemia and Lymphoma Society (US)

Awarded by ARC

Funding Acknowledgements

This work was funded by NHMRC Grants 1016701 (to DLV) and 1057905 (to JMM) and Fellowship 1020136 (to DLV), and Cancer Council Victoria Grant 1044722 (to DLV and WDC), Cure Cancer Australia Foundation Grant 1050301 (to DMM), a Center Grant from Leukemia and Lymphoma Society (US) 7413-07, an ARC Future Fellowship FT100100100 (to JMM), and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS (361646). We thank Toru Okamoto for the doxycycline-inducible vector, Francis Chan for the Fadd<SUP>-/-</SUP> MEFs, Kim Newton and Vishva Dixit for Ripk3<SUP>-/-</SUP> mice and Stephen Hedrick for caspase 8 conditional knockout mice.